HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates

HIV-1 infection can be controlled by anti-retroviral drug therapy, but this is a lifetime treatment and the virus remains latent and rapidly rebounds if therapy is stopped. HIV-1-infected individuals under this drug regimen have increased rates of cancers, cardiovascular diseases, and autoimmunity d...

Descripción completa

Detalles Bibliográficos
Autores principales: Flamar, Anne-Laure, Bonnabau, Henri, Zurawski, Sandra, Lacabaratz, Christine, Montes, Monica, Richert, Laura, Wiedemann, Aurelie, Galmin, Lindsey, Weiss, Deborah, Cristillo, Anthony, Hudacik, Lauren, Salazar, Andres, Peltekian, Cécile, Thiebaut, Rodolphe, Zurawski, Gerard, Levy, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267996/
https://www.ncbi.nlm.nih.gov/pubmed/30500852
http://dx.doi.org/10.1371/journal.pone.0207794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267996/
https://www.ncbi.nlm.nih.gov/pubmed/30500852
http://dx.doi.org/10.1371/journal.pone.0207794

Ejemplares similares